about CritiTech | partners | stay connected | member login | contact | sitemap
Product PortfolioTechnologiesDrug DeliveryServicesNewsInvestors


 


Recent News

October 5, 2012 ::

CritiTech Announces Hire of New Vice President of Technical Operations

Press Release

October 4, 2012 ::

CritiTech Names New Chief Operating Officer

Press Release

July 12, 2012 ::

CritiTech, Inc.(USA) and Finoso Pharma Private Limited (India) enthusiastically announce the formation of a joint venture, FinoTech Pharma!

Press Release

April 15, 2012 :: CritiTech Founder, Dr. Bala Subramaniam to present at International Symposium on Supercritical Fluids in San Francisco, May 13-16. See attached Abstract. Jahna Howell, Director of Lab Operations at CritiTech, to attend as well.
April 13, 2012 :: Planting Saplings in India - (click photos to enlarge)
   

news archive
 
 


CritiTech

CritiTech specializes in optimizing the delivery of challenging drug substances-- potent molecules, poorly soluble compounds and biomolecules. Using our proprietary SCF Technology and our ability to simplify formulations we can extend the potential delivery options to oral, injection, inhalation routes as well as to implantable devices. We thus provide the differentiated products that truly benefit patients in all age groups from pediatric to geriatric. We develop products with significant commercial potential both independently and in collaboration with strategic partners.

Our New C-FPC-411 Crystallizer

Click here for more

 
 


Current Clinical Trials

Nanotax®
(Ovarian Cancer)


Quick Links

eNews
Downloads
Events
Video Portal


Case Studies

CS #106 (Fusion Inhibitor)

CS#107 (Natural Product)

>case archive

 

Popular searches

Fine Particle Production

Medical Device Coating

Drug Coating

Lyphobic Precipitation

Nanotax®

Drug Development

Ovarian Cancer

Peritoneal Cancer

Nanothecin®


© 2011 CritiTech, Inc. : All Rights Reserved     Contact us | Sitemap

 

Fine Particle Production - Medical Device Coating - Drug Coating - Lyphobic Precipitation - Nanotax - Drug Development - Ovarian Cancer - Peritoneal Cancer - Nanothecin

Supercritical Fluid Technology - SCF Technology - Drug Delivery - Crititax - Veterinary Oncology - Submicron - Kansas Cancer - Lyophilization - Micronization - Size Reduction

Particle Design - SCF Precipitation - SCF Crystallization - SCF Crystals - SCF Particle Formation - Supercritical Fluid Precipitation - SCF Anti-solvent